journal article·2023-05Open access

Blockade of Activin Receptor IIB Protects Arthritis Pathogenesis by Non‐Amplification of Activin A‐ACVR2B‐NOX4 Axis Pathway

Jimin Jeon, Hyemi Lee, Min‐Seung Jeon, Seok‐Jung Kim, Cham Choi, Ki Woo Kim, Dong Joo Yang, Sangho Lee, Yong‐Soo Bae, Won Il Choi, Juyeon Jung, Seong‐il Eyun, Siyoung Yang

Advanced Science· Volume 10· Issue 14

Abstract

Abstract Although activin receptor IIB (ACVR2B) is emerging as a novel pathogenic receptor, its ligand and assembled components (or assembly) are totally unknown in the context of osteoarthritis (OA) pathogenesis. The present results suggest that upregulation of ACVR2B and its assembly could affect osteoarthritic cartilage destruction. It is shown that the ACVR2B ligand, activin A, regulates catabolic factor expression through ACVR2B in OA development. Activin A Tg mice (Col2a1‐ Inhba ) exhibit enhanced cartilage destruction, whereas heterozygous activin A KO mice ( Inhba +/− ) show protection from cartilage destruction. In silico analysis suggests that the Activin A‐ACVR2B axis is involved in Nox4‐dependent ROS production. Activin A Tg:Nox4 KO (Col2a1‐ Inhba:Nox4 −/− ) mice show inhibition of experimental OA pathogenesis. NOX4 directly binds to the C‐terminal binding site on ACVR2B‐ACVR1B and amplifies the pathogenic signal for cartilage destruction through SMAD2/3 signaling. Together, the findings reveal that the ACVR2B assembly, which comprises Activin A, ACVR2B, ACVR1B, Nox4, and AP‐1‐induced HIF‐2 α , accelerates OA development. Furthermore, it is shown that shRNA‐mediated ACVR2B knockdown or trapping ligands of ACVR2B abrogate OA development by competitively disrupting the ACVR2B‐Activin A interaction. These results suggest that the ACVR2B assembly is required to amplify osteoarthritic cartilage destruction and could be a potential therapeutic target in efforts to treat OA.
Source: crossref · Quality: baseline

Research context

OpenAlex topics: Inflammatory mediators and NSAID effects · Bone Metabolism and Diseases · TGF-β signaling in diseases

SciVX discovery tags are terminology-based. OpenAlex topics are source-provided classifications.

Affiliations

Department of Biological Sciences Sungkyunkwan University Suwon 16419 Republic of Korea

CIRNO Sungkyunkwan University Suwon 16419 Republic of Korea

Department of Life Science Chung‐Ang University Seoul 06974 Republic of Korea

Department of Orthopaedic Surgery Uijeongbu St. Mary's Hospital The Catholic University of Korea College of Medicine Uijeongbu 11765 Republic of Korea

MicroCT Applications 3rd floor, 11, Sumyeong‐ro 1‐gil, Gangseo‐gu Seoul 07644 Republic of Korea

Department of Oral Biology Yonsei University College of Dentistry Seoul 03722 Republic of Korea

Department of Applied Biological Science BK21 FOUR Yonsei University College of Dentistry Seoul 03722 Republic of Korea

Center for Bio‐Healthcare Materials Bio‐Convergence Materials R&D Division Korea Institute of Ceramic Engineering and Technology Cheongju Chungbuk 28160 Republic of Korea

Bionanotechnology Research Center Korea Research Institute of Bioscience and Biotechnology (KRIBB) Daejeon 34141 Republic of Korea

Funding

National Research Foundation of Korea · Korea Research Institute of Bioscience and Biotechnology

References (76)

Show source-provided references
1. 10.1002/art.3445310.1002/art.34453 ↗
2. 10.1016/j.joca.2016.08.00810.1016/j.joca.2016.08.008 ↗
3. 10.1038/nrrheum.2014.4410.1038/nrrheum.2014.44 ↗
4. 10.1038/nrrheum.2010.19810.1038/nrrheum.2010.198 ↗
5. 10.1002/art.2233710.1002/art.22337 ↗
6. 10.1002/art.2500210.1002/art.25002 ↗
7. 10.1371/journal.pcbi.100580510.1371/journal.pcbi.1005805 ↗
8. 10.1016/j.cell.2013.09.01810.1016/j.cell.2013.09.018 ↗
9. 10.1038/nrrheum.2014.16210.1038/nrrheum.2014.162 ↗
10. 10.1172/JCI6077710.1172/JCI60777 ↗
11. 10.1038/ncomms288010.1038/ncomms2880 ↗
12. 10.1038/nrrheum.2013.7210.1038/nrrheum.2013.72 ↗
13. 10.1097/BOR.000000000000037310.1097/BOR.0000000000000373 ↗
14. 10.1038/nrrheum.2016.6510.1038/nrrheum.2016.65 ↗
15. 10.1016/j.joca.2018.05.02110.1016/j.joca.2018.05.021 ↗
16. 10.1016/j.jaut.2017.06.00610.1016/j.jaut.2017.06.006 ↗
17. 10.2147/OARRR.S17666610.2147/OARRR.S176666 ↗
18. 10.1038/nm81110.1038/nm811 ↗
19. 10.1074/jbc.M113.51057810.1074/jbc.M113.510578 ↗
20. 10.1177/1759720X1771269510.1177/1759720X17712695 ↗
21. 10.1038/s41573-020-0078-410.1038/s41573-020-0078-4 ↗
22. Chevalier X. · J. Rheumatol. · 2005 · 32 · 1317
23. 10.1016/j.joca.2011.12.00910.1016/j.joca.2011.12.009 ↗
24. 10.1073/pnas.190625311610.1073/pnas.1906253116 ↗
25. 10.1016/j.jaut.2019.10231410.1016/j.jaut.2019.102314 ↗
26. 10.1038/s41598-018-19955-110.1038/s41598-018-19955-1 ↗
27. 10.1016/B978-0-12-386931-9.00013-110.1016/B978-0-12-386931-9.00013-1 ↗
28. 10.1016/j.joca.2007.03.00610.1016/j.joca.2007.03.006 ↗
29. 10.1016/j.joca.2016.12.01410.1016/j.joca.2016.12.014 ↗
30. 10.1046/j.1523-1755.2002.00463.x10.1046/j.1523-1755.2002.00463.x ↗
31. 10.1038/nm.215310.1038/nm.2153 ↗
32. 10.1038/374354a010.1038/374354a0 ↗
33. 10.1136/annrheumdis-2014-20629510.1136/annrheumdis-2014-206295 ↗
34. 10.1038/s41467-021-24108-610.1038/s41467-021-24108-6 ↗
35. 10.1016/j.joca.2015.02.16710.1016/j.joca.2015.02.167 ↗
36. 10.1074/jbc.M111.33249410.1074/jbc.M111.332494 ↗
37. 10.3390/biom1004051910.3390/biom10040519 ↗
38. 10.1016/j.cytogfr.2015.11.00510.1016/j.cytogfr.2015.11.005 ↗
39. 10.1073/pnas.050003110210.1073/pnas.0500031102 ↗
40. 10.1074/jbc.M20657120010.1074/jbc.M206571200 ↗
41. 10.1038/nrc120910.1038/nrc1209 ↗
42. 10.1021/jm050550d10.1021/jm050550d ↗
43. 10.1038/boneres.2014.4210.1038/boneres.2014.42 ↗
44. 10.1074/jbc.M115.71348710.1074/jbc.M115.713487 ↗
45. 10.1038/s41598-017-07963-610.1038/s41598-017-07963-6 ↗
46. 10.1158/1078-0432.CCR-15-074310.1158/1078-0432.CCR-15-0743 ↗
47. 10.1074/jbc.M113.51057810.1074/jbc.M113.510578 ↗
48. 10.1002/art.2409610.1002/art.24096 ↗
49. 10.1186/ar343010.1186/ar3430 ↗
50. 10.1016/j.jbc.2022.10207610.1016/j.jbc.2022.102076 ↗
51. 10.1038/s41598-019-57011-810.1038/s41598-019-57011-8 ↗
52. 10.1006/dbio.2000.998110.1006/dbio.2000.9981 ↗
53. 10.1359/jbmr.2002.17.3.51310.1359/jbmr.2002.17.3.513 ↗
54. 10.1016/S0925-4773(03)00067-410.1016/S0925-4773(03)00067-4 ↗
55. 10.1073/pnas.200056111710.1073/pnas.2000561117 ↗
56. 10.1183/13993003.02341-202010.1183/13993003.02341-2020 ↗
57. 10.1101/gad.12.6.84410.1101/gad.12.6.844 ↗
58. 10.1038/jid.2010.40010.1038/jid.2010.400 ↗
59. 10.1210/jc.2015-213410.1210/jc.2015-2134 ↗
60. 10.1124/mol.62.1.5810.1124/mol.62.1.58 ↗
61. 10.1371/journal.pone.006272110.1371/journal.pone.0062721 ↗
62. Raje N. · Curr. Opin. Mol. Ther. · 2010 · 12 · 586
63. 10.1016/j.cytogfr.2020.09.00310.1016/j.cytogfr.2020.09.003 ↗
64. 10.1016/j.cell.2014.01.00710.1016/j.cell.2014.01.007 ↗
65. 10.1172/JCI13810710.1172/JCI138107 ↗
66. 10.1002/jbmr.14110.1002/jbmr.141 ↗
67. 10.1007/s10856-018-6066-010.1007/s10856-018-6066-0 ↗
68. 10.1038/nprot.2008.9510.1038/nprot.2008.95 ↗
69. 10.1002/smll.20220214610.1002/smll.202202146 ↗
70. 10.1073/pnas.190898111610.1073/pnas.1908981116 ↗
71. 10.1007/s00441-021-03564-y10.1007/s00441-021-03564-y ↗
72. 10.1186/s12935-022-02598-810.1186/s12935-022-02598-8 ↗
73. 10.1073/pnas.050658010210.1073/pnas.0506580102 ↗
74. 10.1093/bioinformatics/bti77010.1093/bioinformatics/bti770 ↗
75. 10.1038/s41586-021-03819-210.1038/s41586-021-03819-2 ↗
76. 10.1093/bioinformatics/btx21610.1093/bioinformatics/btx216 ↗